Applications of Digital Polymerase Chain Reaction (dPCR) in Molecular and Clinical Testing

Area of Science:

• Molecular Biology
• Biotechnology
• Clinical Diagnostics

Background:

• Digital polymerase chain reaction (dPCR) is a highly sensitive and accurate molecular diagnostic tool.
• Its core principle involves partitioning reactions into thousands of nano- or picoliter-sized compartments.
• This enables the detection of rare nucleic acid targets and absolute quantification of sequences.

Purpose of the Study:

• To highlight the capabilities and applications of dPCR technology in clinical settings.
• To compare the sensitivity and accuracy of dPCR with quantitative PCR (qPCR).
• To explore current and future clinical uses of dPCR.

Main Methods:

• Partitioning of a single reaction into numerous nano- or picoliter-sized reactions (e.g., droplets, nanochannels).
• Utilizing dPCR platforms with varying partitioning methods, automation, and multiplexing capabilities.
• Application in sensitive and accurate quantification of nucleic acid targets.

Main Results:

• dPCR demonstrates increased sensitivity and accuracy compared to qPCR.
• The technology excels in detecting rare targets, such as variants in cell-free DNA and circulating tumor DNA.
• Commercial dPCR tests are emerging for clinically significant variants.

Conclusions:

• dPCR provides precise absolute quantification and enhanced sensitivity for molecular testing.
• Current clinical applications span oncology, infectious diseases, genetics, and prenatal screening.
• Future applications include liquid biopsies, minimal residual disease screening, and monitoring transplant engraftment.